iZafe Group AB (OSTO:IZAFE B) Debt-to-Equity : 0.13 (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is iZafe Group AB Debt-to-Equity?

iZafe Group AB's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was kr1.05 Mil. iZafe Group AB's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was kr1.59 Mil. iZafe Group AB's Total Stockholders Equity for the quarter that ended in Mar. 2024 was kr19.83 Mil. iZafe Group AB's debt to equity for the quarter that ended in Mar. 2024 was 0.13.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for iZafe Group AB's Debt-to-Equity or its related term are showing as below:

OSTO:IZAFE B' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.02 Med: 0.17 Max: 1.28
Current: 0.13

During the past 13 years, the highest Debt-to-Equity Ratio of iZafe Group AB was 1.28. The lowest was 0.02. And the median was 0.17.

OSTO:IZAFE B's Debt-to-Equity is ranked better than
62.89% of 698 companies
in the Medical Devices & Instruments industry
Industry Median: 0.215 vs OSTO:IZAFE B: 0.13

iZafe Group AB Debt-to-Equity Historical Data

The historical data trend for iZafe Group AB's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iZafe Group AB Debt-to-Equity Chart

iZafe Group AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.30

0.03

0.12

0.10

iZafe Group AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial															0.07	0.06	0.07	0.10	0.13

Competitive Comparison of iZafe Group AB's Debt-to-Equity

For the Medical Instruments & Supplies subindustry, iZafe Group AB's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

iZafe Group AB's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, iZafe Group AB's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where iZafe Group AB's Debt-to-Equity falls into.

iZafe Group AB Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

iZafe Group AB's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.037	+	1.487)	/	25.353
	=	0.10

iZafe Group AB's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.048	+	1.591)	/	19.832
	=	0.13

iZafe Group AB (OSTO:IZAFE B) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

iZafe Group AB Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of iZafe Group AB's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

iZafe Group AB (OSTO:IZAFE B) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » iZafe Group AB (OSTO:IZAFE B) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Grev Turegatan 11A, Stockholm, SWE, 114 46

Website

https://www.izafe.se

iZafe Group AB is a pure Life-Science company engaged in the development of digital drug dispensing. The company conducts research, development and marketing of digital medical solutions and services for safer drug management at home. iZafe's drug robot Dosell is used to reduce the risk of incorrect medication at home, relieve public care, increase the patient's quality of life and create a safer environment for relatives. The customers consist of public and private care providers in Sweden, the Nordic countries and globally. iZafe sells through well-established partners who already have long and deep customer relationships with the priority customer groups.

iZafe Group AB (OSTO:IZAFE B) Headlines

No Headlines